Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Tourmaline Bio Inc.

Headquarters: New York, NY, United States of America
Year Founded: 2021
Status: Public
Industry Sector: HealthTechnology
CEO: Sandeep C. Kulkarni, MD
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -6.53
Exchange/Ticker 1: NASDAQ:TRML
Exchange/Ticker 2: N/A
Latest Market Cap: $482,080,896

BioCentury | Feb 3, 2024
Finance

Series A companies: the class of 2023

An analysis of the technologies behind last year’s biotech series A raisers finds clusters in mitophagy induction, epigenome editing and delivery vectors
BioCentury | Jan 27, 2024
Finance

Public equity roundup: CG, ArriVent IPOs stoke optimism for growing queue

Plus: Follow-ons for Sagimet, Tourmaline and Adicet, and PIPEs for Kura, ORIC and CalciMedica
BioCentury | Dec 20, 2023
Data Byte

2023’s biotech reverse mergers

Half of the U.S.-listed biotechs that announced reverse mergers this year had been public for four years or less
BioCentury | Dec 16, 2023
Management Tracks

Mistras, Martin join Viatris

Plus: Nassim Usman at the helm at Totus as it raises $66M series B round, and updates from Tourmaline, HKEX, CIRM, CorMedix and RiverVest
BioCentury | Jun 23, 2023
Deals

June 22 Quick Takes: Spyre launches onto NASDAQ via Aeglea merger

Plus: Tourmaline reverse-merging with Talaris, CAR T shows early efficacy in myasthenia gravis, and updates from AltPep, Solve and Intercept
Items per page:
1 - 5 of 5